Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAFAEL: Rosiglitazone and Fenofibrate Effects on Lipids
NCT00819910Phase 4Terminated
- Start
- Sep 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rosiglitazone in hypertriglyceridemia, Type 4 hyperlipoproteinemia. Started Sep 2008; status: terminated.
02
Drugs
rosiglitazone
03
Conditions
hypertriglyceridemiaType 4 hyperlipoproteinemia
Beyond the preview
Go deeper on NCT00819910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00819910.